Prevention of Seasonal Affective Disorder
Public ClinicalTrials.gov record NCT00046449. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00046449
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GlaxoSmithKline
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Investigational Seasonal Affective Disorder (SAD) Drug Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2002
- Primary completion
- May 31, 2003
- Completion
- May 31, 2003
- Last update posted
- Jun 3, 2015
2002 – 2003
United States locations
- U.S. sites
- 47
- U.S. states
- 19
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site | Homer | Alaska | 99603 | — |
| Study Site | New Haven | Connecticut | 06504-0605 | — |
| Study Site | Newark | Delaware | 19713 | — |
| Study Site | Wilmington | Delaware | 19808-1251 | — |
| Study Site | Washington D.C. | District of Columbia | 20016 | — |
| Study Site | Washington D.C. | District of Columbia | 20037 | — |
| Study Site | Boise | Idaho | 83704 | — |
| Study SIte | Chicago | Illinois | 60610 | — |
| Study Site | Chicago | Illinois | 60612 | — |
| Study Site | Hoffman Estates | Illinois | 60194 | — |
| Study Site | Libertyville | Illinois | 60048 | — |
| Study SIte | Northfield | Illinois | 60093 | — |
| Study Site | Schaumburg | Illinois | 60194 | — |
| Study SIte | Greenwood | Indiana | 46143 | — |
| Study Site | Indianapolis | Indiana | 45202 | — |
| Study Site | Florence | Kentucky | 41042 | — |
| Study Site | Wellesley Hills | Massachusetts | 02481 | — |
| Study Site | Okemos | Michigan | 48864 | — |
| Study Site | Royal Oak | Michigan | 48067 | — |
| Study Site | Minneapolis | Minnesota | 55454 | — |
| Study Site | Moorestown | New Jersey | 08057 | — |
| Study Site | Piscataway | New Jersey | 08854 | — |
| Study Site | Amityville | New York | 11701 | — |
| Study Site | Lawrence | New York | 11559 | — |
| Study Site | New York | New York | 10021 | — |
| Study Site | Olean | New York | 14760 | — |
| Study Site | Staten Island | New York | 10305 | — |
| Study Site | Williamsville | New York | 14221 | — |
| Study Site | Cincinnati | Ohio | 45219 | — |
| Study Site | Cleveland | Ohio | 44106 | — |
| Study Site | Cleveland | Ohio | 44121 | — |
| Study Site | Independence | Ohio | 44131 | — |
| Study Site | Lyndhurst | Ohio | 44124 | — |
| Study Site | Toledo | Ohio | 43623 | — |
| Study Site | Eugene | Oregon | 97401 | — |
| Study Site | Portland | Oregon | 97201 | — |
| Study Site | Portland | Oregon | 97209 | — |
| Study Site | Salem | Oregon | 97309 | — |
| Study Site | Allentown | Pennsylvania | 18104 | — |
| Study Site | Philadelphia | Pennsylvania | 19106 | — |
| Study Site | Philadelphia | Pennsylvania | 19107 | — |
| Study Site | Lincoln | Rhode Island | 02865-4208 | — |
| Study Site | Seattle | Washington | 98104 | — |
| Study Site | Madison | Wisconsin | 53719 | — |
| Study Site | Middleton | Wisconsin | 53562 | — |
| Study Site | Milwaukee | Wisconsin | 53226 | — |
| Study Site | West Allis | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00046449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00046449 live on ClinicalTrials.gov.